Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in dr reddys

DRDO Develops Survival Kit For Troops Deployed At Minus 50 Degrees Celcius

Import substitution technology for extreme cold weather gear handed over to 5 Indian companies

Read More

Mansukh Mandaviya Holds Meeting With Dr Reddy's Lab Chairman On Sputnik V Production, Supply

The Hyderabad-based drug major has already stated that the locally manufactured Sputnik V will be available from September-October period.

Read More

Sputnik V Soft Launched In Over 50 Cities In India: Dr Reddys

The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.

Read More

Dr Reddy's Bullish On OTC Products Sale Through Amazon, Others In US

Dr Reddys had three late projects at different levels of development, ranging from products that have completed Phase 2 clinical trials to a product that is undergoing pivotal studies for registration.

Read More

Dr Reddy's Expects Biz Growth To Be Volatile In Current Fiscal

Higher productivity is also enabled by scaling up of robotic process automation (RPAs) as well as digitalised processes with automated incident tracking and near zero manual errors

Read More

Dr Reddy's Lines Up Rs 1,000 Cr Capex For Current Fiscal

The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications and capability ramp-up in marketing and digitalisation

Read More

Dr Reddy's In Talks With RDIF On Sputnik V For Other Countries

RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September

Read More

Dr Reddy's Q4 Profit Dips 29 Pc To Rs 557 Cr

Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20

Read More

Dr Reddy's Inks Licensing Pact With Eli Lilly For COVID-19 Treatment Drug

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.

Read More

Dr Reddy's Launches Generic Drug In US Market

The Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.

Read More

Lindstrom To Launch Its First Clean Room Service In Pune In March 2018

Lindstrom India, a subsidiary of Lindstrom Group, a Finnish workwear service company which has completed 170 years of its existence, is the only organized rental workwear services company in India. Juha Laurio, President & CEO, Lindstrom, Finland & Anupam Chakrabarty, Managing Director, Lindstrom, India, speak to BW Businessworld on the launch of their first clean room service in Pune in March 2018, the new opportunities in healthcare, food sector and how does Lindstrom support sustainability

Read More

Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge

The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.

Read More

Dr Reddy's Says German Regulator Makes Six Observations On Unit

Dr. Reddy's, in an exchange filing, did not however elaborate on the observations, which typically refer to aspects of the production process that must be improved in order to gain regulatory approval for exports

Read More

India Eyes Oil-For-Drugs Deal With Venezuela To Recoup Pharma Cash

Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies

Read More